White House: Shield Biotech Drugs From Generics For Only Seven Years

White House officials said Thursday that biotech drugs (also known as biologics) should only be protected from generics competition for seven years, Reuters reports. “The amount of protection for brand-name companies is a sticking point among lawmakers working to set up a legal pathway for approval of generic forms of biotech drugs.

More: continued here

Filed under: Pharma Industry on June 30th, 2009